Mitsubishi UFJ Asset Management Co. Ltd. Buys 27,935 Shares of Humana Inc. (NYSE:HUM)

Key Points

• Mitsubishi UFJ Asset Management increased its stake in Humana Inc. by 14.8%, acquiring an additional 27,935 shares to reach a total of 216,728 shares valued at approximately $57 million.
• Institutional investors collectively own 92.38% of Humana's stock, with significant increases from firms like Ontario Teachers Pension Plan Board and Vanguard Group Inc.
• Humana reported quarterly earnings of $6.27 per share, slightly missing analysts' expectations, and had revenues of $32.39 billion, showing a 9.6% year-over-year increase.

Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 14.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 216,728 shares of the insurance provider's stock after acquiring an additional 27,935 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.18% of Humana worth $57,346,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Revolve Wealth Partners LLC bought a new position in shares of Humana in the fourth quarter valued at approximately $202,000. Raymond James Financial Inc. bought a new position in shares of Humana during the 4th quarter worth about $26,720,000. Bessemer Group Inc. increased its holdings in shares of Humana by 2.0% during the 4th quarter. Bessemer Group Inc. now owns 6,518 shares of the insurance provider's stock worth $1,655,000 after purchasing an additional 125 shares during the period. Scotia Capital Inc. increased its holdings in shares of Humana by 44.2% during the 4th quarter. Scotia Capital Inc. now owns 953 shares of the insurance provider's stock worth $242,000 after purchasing an additional 292 shares during the period. Finally, Colonial Trust Advisors increased its stake in Humana by 4,500.0% in the fourth quarter. Colonial Trust Advisors now owns 184 shares of the insurance provider's stock valued at $47,000 after acquiring an additional 180 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Up 0.2%

HUM traded up $0.51 during midday trading on Monday, hitting $267.19. The company had a trading volume of 1,749,494 shares, compared to its average volume of 2,029,327. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $382.72. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $32.13 billion, a price-to-earnings ratio of 13.44, a PEG ratio of 1.57 and a beta of 0.44. The stock's 50 day moving average price is $237.88 and its 200 day moving average price is $253.89.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the previous year, the business earned $6.96 earnings per share. The firm's revenue for the quarter was up 9.6% on a year-over-year basis. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Bank of America lowered their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th. Barclays set a $275.00 target price on shares of Humana and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Truist Financial decreased their price objective on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Morgan Stanley decreased their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Finally, Robert W. Baird decreased their price objective on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $281.62.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.